Market Place
Sourcing Support
BiomX Reports Q1 2024 Results, Program Updates
21 May 2024 //
GLOBENEWSWIRE
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results
03 Apr 2024 //
GLOBENEWSWIRE
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics
18 Mar 2024 //
GLOBENEWSWIRE
BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics
06 Mar 2024 //
GLOBENEWSWIRE
Adaptive Phage Closes on $12 Million Investment in $30 Million Series B1
13 Jun 2023 //
BUSINESSWIRE
Adaptive Phage Therapeutics Enters Collaboration and License Agreement
24 May 2023 //
BUSINESSWIRE
Adaptive Phage Therapeutics Announces First Patient Dosed in the PHAGE Trial
12 Jan 2023 //
BUSINESSWIRE
Adaptive Phage Therapeutics Appoints Edward Fang as Chief Medical Officer
25 Oct 2022 //
BUSINESSWIRE
Adaptive Announces "The AMR RAPID Challenge" for Infectious Disease Community
07 Sep 2022 //
BUSINESSWIRE
Adaptive Phage Begins Dosing in DANCE Trial, PI/II Study of APT Phage Bank
18 May 2022 //
BUSINESSWIRE
Adaptive Phage Appoints Rob Casper as Vice President of Clinical Operations
26 Apr 2022 //
BUSINESSWIRE
Adaptive Phage Tx Extends Series B to $61M with Addition of The AMR Action Fund
04 Apr 2022 //
BUSINESSWIRE
Adaptive Phage Awarded Additional $8M from US Department of Defense
30 Sep 2021 //
BUSINESSWIRE
Adaptive Phage Therapeutics Report Publication of Case Study of a Phage Therapy
09 Sep 2021 //
BUSINESSWIRE
Adaptive Phage Therapeutics to Present at the FDA and NIH Hosted Workshop
24 Aug 2021 //
BUSINESSWIRE
Adaptive Phage Therapeutics Appoints Robert J. Hopkins to Chief Medical Officer
30 Jul 2021 //
BUSINESS WIRE
Adaptive Phage Therapeutics Expands Board Following Series B Financing
29 Jun 2021 //
BUSINESSWIRE
Adaptive Phage Therapeutics Announces Collaboration with Oyster Point Pharma
10 Jun 2021 //
BUSINESSWIRE
Adaptive Phage Therapeutics Announces $40.75 Million Series B Financing
11 May 2021 //
BUSINESSWIRE
Adaptive Phage Announces FDA Clearance of IND Application for PhageBank™
10 Mar 2021 //
BIOSPACE
Adaptive Phage Announces FDA Clearance of IND Application for PhageBank™
09 Mar 2021 //
BUSINESSWIRE
Adaptive Phage Announces FDA Clearance of IND Application for PhageBank™
10 Feb 2021 //
BIOSPACE
Adaptive Phage Therapeutics Receives Orphan Drug Designation for PhageBank™
22 Oct 2020 //
BUSINESSWIRE
Adaptive Phage Announces Mayo Clinic Lead Investor in Convertible Note Financing
05 Aug 2020 //
BUSINESSWIRE
FDA Clears First Clinical Study for a Polymicrobial Phage
12 Mar 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.